Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
An erratum to this article was published (Diabetes Care, 1 Nov 2024 ↗)
Recommendations
As issued by the authors
Partnerships should be fostered between endocrinologists and primary care providers to care for people who are IAb+
When people who are IAb+ are initially identified, confirmation using a second sample is needed
Single IAb+ individuals are at lower risk of progression than multiple IAb+ individuals
Individuals with early-stage T1D should have periodic medical monitoring, including regular glucose assessments, regular education about symptoms of DM and diabetic ketoacidosis (DKA), and psychosocial support
Interested people with stage 2 T1D should be offered trial participation or approved therapies
All health professionals involved in monitoring and care of individuals with T1D have a responsibility to provide education
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →